Paperpal Prime Logo

Medicinal Chemistry Research : Impact Factor & More

eISSN: 1554-8120pISSN: 1054-2523

Key Metrics

CiteScore
3.8
H-Index
56
Impact Factor
< 5
SJR
Q2Organic Chemistry
SNIP
0.77
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Medicinal Chemistry Research

Medicinal Chemistry Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER BIRKHAUSER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Medicinal Chemistry Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Medicinal Chemistry Research

Small-molecule ferroptosis inducers and sensitizers in anticancer drug discovery: medicinal chemistry, structure-activity relationships, and translational perspectives.
  • 24 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Azole chroman-4-one, tetralone and chromen-4-one derivatives: synthesis, Mycobacterium tuberculosis CYP121A1 enzyme inhibition and antimycobacterial activity.
  • 23 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Structure-based discovery of acridone alkaloids as disruptors of the HEG1-KRIT1 protein-protein interaction in cerebral cavernous malformation signaling.
  • 13 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Coumarin scaffolds in breast cancer research: derivatives, hybrids, and therapeutic potential.
  • 13 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Bicyclononane-2,8-bis(trifluoromethyl)quinoline hybrids: synthesis, antiplasmodial and antitrypanosomal activity.
  • 6 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation.
  • 1 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Small-molecule ferroptosis inducers and sensitizers in anticancer drug discovery: medicinal chemistry, structure-activity relationships, and translational perspectives.
  • 24 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Azole chroman-4-one, tetralone and chromen-4-one derivatives: synthesis, Mycobacterium tuberculosis CYP121A1 enzyme inhibition and antimycobacterial activity.
  • 23 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Structure-based discovery of acridone alkaloids as disruptors of the HEG1-KRIT1 protein-protein interaction in cerebral cavernous malformation signaling.
  • 13 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Coumarin scaffolds in breast cancer research: derivatives, hybrids, and therapeutic potential.
  • 13 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Bicyclononane-2,8-bis(trifluoromethyl)quinoline hybrids: synthesis, antiplasmodial and antitrypanosomal activity.
  • 6 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation.
  • 1 Oct 2026
  • Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

FAQs on Medicinal Chemistry Research